A cohort study of pediatric shock: Frequency of corticosteriod use and association with clinical outcomes

Shock

Volumn 44, Issue 5, 2015, Pages 402-409

  Menon, Kusum ^a   Dayre McNally, J ^a   Choong, Karen ^b   Lawson, Margaret L ^b   Ramsay, Tim ^c   Wong, Hector R ^d  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Corticosteroids; hydrocortisone; pediatric critical care; pediatric critical illness; septic shock; shock

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; HYPERTENSIVE FACTOR; METHYLPREDNISOLONE; PREDNISONE; VASOACTIVE AGENT; GLUCOCORTICOID; VASOCONSTRICTOR AGENT;

ARTICLE; ARTIFICIAL VENTILATION; CANADA; CHILD; CHILDHOOD DISEASE; CHILDHOOD INJURY; COHORT ANALYSIS; CORTICOSTEROID THERAPY; CRITICAL ILLNESS; DISEASE COURSE; DISEASE SEVERITY; DRUG USE; FEMALE; FLUID RESUSCITATION; GASTROINTESTINAL HEMORRHAGE; HEART SURGERY; HOSPITAL ADMISSION; HUMAN; INOTROPISM; INSULIN INFUSION; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEWBORN; PROPHYLAXIS; RETROSPECTIVE STUDY; SEPTIC SHOCK; SHOCK; ADOLESCENT; CHEMICALLY INDUCED; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG UTILIZATION; EPIDEMIOLOGY; HOSPITAL MORTALITY; INFANT; MORTALITY; MULTICENTER STUDY; ONTARIO; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG UTILIZATION; FEMALE; GLUCOCORTICOIDS; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; MALE; ONTARIO; OPPORTUNISTIC INFECTIONS; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; SHOCK; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84943170226     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000355     Document Type: Article

References (35)

1. Pollack MM, Patel KM, Ruttimann UE: PRISM III: an updated Pediatric Risk of Mortality score. Crit Care Med 24(5):743-752, 1996.
2. Valoor HT, Singhi S, Jayashree M: Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting. Pediatr Crit Care Med 10(1):121-125, 2009.
3. Slusher T, Gbadero D, Howard C, Lewison L, Giroir B, Toro L, Levin D, Holt E, McCracken G: Randomized, placebo-controlled, double blinded trial of dexa-methasone in African children with sepsis. Pediatr Infect Dis J 15(7):579-583, 1996.
4. Odetola FO, Gebremariam A, Freed GL: Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics 119(3):487-494, 2007.
5. Kissoon N, Carcillo JA, Espinosa V, Argent A, Devictor D, Madden M, Singhi S, Van Der V, Latour J: World Federation of Pediatric Intensive Care andCritical Care Societies: Global Sepsis Initiative. Pediatr Crit Care Med 12(5):494-503, 2011.
6. Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, Macias WL, bd-Allah SA, Levy H, Angle R, Wang D, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 369(9564):836-843, 2007.
7. Menon K, McNally JD, Choong K, Ward RE, Lawson ML, Ramsay T: A Survey of Stated Physician Practices and Beliefs on the Use of Steroids in Pediatric Fluid and/or Vasoactive Infusion-Dependent Shock. Pediatr Crit Care Med 14(5):462-466, 2013.
8. Ando M, Park IS, Wada N, Takahashi Y: Steroid supplementation: a legitimate pharmacotherapy after neonatal open heart surgery. Ann Thorac Surg 80(5):1672-1678, 2005.
9. Choong K, Bohn D, Fraser DD, Gaboury I, Hutchison JS, Joffe AR, Litalien C, Menon K, McNamara P, Ward RE: Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 180(7):632-639, 2009.
10. Menon K, Ward RE, Lawson ML, Gaboury I, Hutchison JS, Hebert PC: A prospective multicenter study of adrenal function in critically ill children. Am J Respir Crit Care Med 182(2):246-251, 2010.
11. Sasidharan P: Role of corticosteroids in neonatal blood pressure homeostasis. Clin Perinatol 25(3):723-740, 1998.
12. Hinshaw LB, Beller BK, Chang AC, Murray CK, Flournoy DJ, Passey RB, Archer LT: Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock 16(3):265-277, 1985.
13. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358(2):111-124, 2008.
14. Pasquali SK, Hall M, Li JS, Peterson ED, Jaggers J, Lodge AJ, Marino BS, Goodman DM, Shah SS: Corticosteroids and outcome in children undergoing congenital heart surgery: analysis of the Pediatric Health Information Systems database. Circulation 122(21):2123-2130, 2010.
15. Costello JM, Graham DA, Morrow DF, Morrow J, Potter-Bynoe G, Sandora TJ, Pigula FA, Laussen PC: Risk factors for surgical site infection after cardiac surgery in children. Ann Thorac Surg 89(6):1833-1841, 2010.
16. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky MD, Sprung CL, Douglas IS, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 39(2):165-228, 2013.
17. Menon K, Lawson M: Identification of adrenal insufficiency in pediatric critical illness. Pediatr Crit Care Med 8(3):276-278, 2007.
18. Averill RF, Mullin RL, Steinbeck BA, Goldfield NI, Grant TM: Development of the ICD-10 procedure coding system (ICD-10-PCS). Top Health Inf Manage 21(3):54-88, 2001.
19. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7):862-871, 2002.
20. Atkinson SJ, Cvijanovich NZ, Thomas NJ, Allen GL, Anas N, Bigham MT, Hall M, Freishtat RJ, Sen A, Meyer K, et al. Corticosteroids and pediatric septic shock outcomes: a risk stratified analysis. PLoS One 9(11):e112702, 2014.
21. den Brinker M, Joosten KF, Liem O, de Jong FH, Hop WC, Hazelzet JA, van Dijk M, Hokken-Koelega AC: Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 90(9):5110-5117, 2005.
22. Beishuizen A, Thijs LG, Vermes I: Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit Care 6(5):434-438, 2002.
23. Cooper MS, Stewart PM: Adrenal insufficiency in critical illness: J Intensive Care Med 22(6):348-362, 2007.
24. Peeters RP, Hagendorf A, Vanhorebeek I, Visser TJ, Klootwijk W, Mesotten D, Wouters PJ, Koper JW, de Jong FH, Feelders RA, et al. Tissue mRNA expression of the glucocorticoid receptor and its splice variants in fatal critical illness. Clin Endocrinol (Oxf) 71(1):145-153, 2009.
25. Annane D: Defining critical illness-related corticosteroid insufficiency: one step forward! Crit Care Med 38(2):721-722, 2010.
26. Goldstein B, Giroir B, Randolph A: International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6(1):2-8, 2005.
27. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De GR, Keh D, Kupfer Y, Oppert M, Meduri GU: Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 301(22):2362-2375, 2009.
28. Markovitz BP, Goodman DM, Watson RS, Bertoch D, Zimmerman J: A retrospective cohort study of prognostic factors associated with outcome in pediatric severe sepsis: what is the role of steroids? Pediatr Crit Care Med 6(3):270-274, 2005.
29. Wehling M: Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59:365-393, 1997.
30. Seri I, Evans J: Controversies in the diagnosis and management of hypotension in the newborn infant. Curr Opin Pediatr 13(2):116-123, 2001.
31. Munck A, Mendel DB, Smith LI, Orti E: Glucocorticoid receptors and actions. Am Rev Respir Dis 141(2 Pt 2):S2-S10, 1991.
32. Menon K, McNally D, Choong K, Sampson M: A systematic review and metaanalysis on the effect of steroids in pediatric shock. Pediatr Crit Care Med 14(5):474-480, 2013.
33. Funk D, Doucette S, Pisipati A, Dodek P, Marshall JC, Kumar A: Low-dose corticosteroid treatment in septic shock: a propensity-matching study∗. Crit Care Med 42(11):2333-2341, 2014.
34. Katsenos CS, Antonopoulou AN, Apostolidou EN, Ioakeimidou A, Kalpakou GT, Papanikolaou MN, Pistiki AC, Mpalla MC, Paraschos MD, Patrani MA, et al. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response∗. Crit Care Med 42(7):1651-1657, 2014.
35. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS: Trends in the epidemiology of pediatric severe sepsis∗. Pediatr Crit Care Med 14(7):686-693, 2013.